Malaysia
Argentina 
Australia 
Austria 
Brazil 
Canada 
Germany 
Ireland 
Italy 
Mexico 
New Zealand 
Poland 
South Africa 
United Kingdom 
United States Antimicrobial resistance
Countries in the WHO European Region commit to action on antimicrobial resistance by endorsing a new European Roadmap. Health ministers and delegates from WHO/Europe's 53 Member States have endorsed the new European Roadmap on antimicrobial resistance (AMR), which supports countries in the WHO European Region to identify, prioritize, and implement high-impact interventions.
Antimicrobial resistance is a growing global concern that poses a significant threat to public health. It occurs when microorganisms such as bacteria, viruses, fungi, and parasites develop resistance to the drugs that were previously effective in treating them. This can lead to longer and more severe illnesses, increased healthcare costs, and higher mortality rates.
The new European Roadmap on antimicrobial resistance aims to address this urgent issue by providing a strategic framework for countries in the WHO European Region. It emphasizes the importance of surveillance, prevention, and control measures to combat antimicrobial resistance. By identifying and implementing high-impact interventions, countries can reduce the spread of resistant microorganisms and preserve the effectiveness of existing antimicrobial drugs.
